Bromfenac Sodium
Tier C — Watch / tradeBromfenac Sodium
Targets：COXs
Brand：BromSite, Yellox, Remura, XiDay (former Brand Name), Prolensa, Bromday, Bronuck, Duract, Xibrom QD, Xibrom
Indications (approved)：Inflammatory disease, Postoperative pain, 眼睛发炎, 眼睛疼痛
Regional status
Factories producing this API1
Factories registered as producing this API in our sourcing network (RFQ records + product master), sorted by RFQ activity; the snapshot carries no cost or customer data.
1 producing factories on file — sign in to view the named list (factory details are not shown to guests).
Sign in to view factories →Synthetic routes & intermediates
Frequently asked questions
What are the approved indications of Bromfenac Sodium?
Approved indications include: Inflammatory disease, Postoperative pain, 眼睛发炎, 眼睛疼痛.
When does the Bromfenac Sodium patent expire?
No public expiry year is available for Bromfenac Sodium yet; this page updates once verified.
How do I get a quote for Bromfenac Sodium intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-27